Silence Therapeutics plc (SLNCF)
OTCMKTS
· Delayed Price · Currency is USD
0.9700
0.00 (0.00%)
May 8, 2025, 4:00 PM EDT
Silence Therapeutics Market Cap
Silence Therapeutics has a market cap or net worth of $168.12 million as of May 9, 2025. Its market cap has decreased by -83.98% in one year.
Market Cap
168.12M
Enterprise Value
31.65M
Revenue
27.70M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.97
Market Cap Chart
Since September 8, 2020, Silence Therapeutics's market cap has decreased from 538.37M to 168.12M, a decrease of -68.77%. That is a compound annual growth rate of -22.08%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 8, 2025 | 168.12M | -48.25% |
Dec 31, 2024 | 324.84M | -51.64% |
Dec 29, 2023 | 671.70M | 22.71% |
Dec 30, 2022 | 547.37M | -23.44% |
Dec 31, 2021 | 714.99M | 17.04% |
Dec 31, 2020 | 610.91M | 13.47% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Endo Inc. | 1.67B |
Nika Pharmaceuticals | 1.02B |
Veradigm | 761.84M |
Tian'an Technology Group | 568.98M |
Glass House Brands | 484.30M |
CytoDyn | 482.88M |
Elite Pharmaceuticals | 448.25M |
Northwest Biotherapeutics | 390.49M |